alanine has been researched along with oxidopamine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, EB; Fedorak, RN; Field, M; Madara, JL | 1 |
| Ding, JH; Hu, G; Li, H | 1 |
| Brugnoli, A; Caccia, C; Gardoni, F; Keywood, C; Kulisevsky, J; Mellone, M; Melloni, E; Morari, M; Novello, S; Padoani, G; Pisanò, CA; Sosti, V; Vailati, S | 1 |
| Brugnoli, A; Caccia, C; Keywood, C; Melloni, E; Morari, M; Novello, S; Padoani, G; Pisanò, CA; Vailati, S | 1 |
| Bastioli, G; Caccia, C; Calabresi, P; Cardinale, A; Ghiglieri, V; Keywood, C; Mazzocchetti, P; Melloni, E; Mosci, P; Padoani, G; Picconi, B; Sciaccaluga, M; Tozzi, A; Vailati, S | 1 |
| Alexandre Scorza, F; Augusto Izidoro, M; Finsterer, J; Goncalves, VC; Guimarães de Almeida, AC; Luiz Affonso Fonseca, F; Scorza, CA; Silva da Fonsêca, V | 1 |
6 other study(ies) available for alanine and oxidopamine
| Article | Year |
|---|---|
Intestinal adaptation to diabetes. Altered Na-dependent nutrient absorption in streptozocin-treated chronically diabetic rats.
Topics: 3-O-Methylglucose; Alanine; Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Hydroxydopamines; Ileum; Intestinal Absorption; Jejunum; Kinetics; Male; Methylglucosides; Microvilli; Oxidopamine; Phlorhizin; Rats; Rats, Inbred Lew; Sodium; Streptozocin; Sulfates; Sympathectomy, Chemical | 1987 |
Group I mGluR ligands fail to affect 6-hydroxydopamine- induced death and glutamate release of PC12 cells.
Topics: Adrenergic Agents; Alanine; Animals; Apoptosis; Cell Survival; DNA Fragmentation; Drug Interactions; Glutamic Acid; Ligands; Methoxyhydroxyphenylglycol; Oxidopamine; PC12 Cells; Rats; Receptors, Metabotropic Glutamate | 2003 |
Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia.
Topics: Alanine; Animals; Antiparkinson Agents; Benzylamines; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Dyskinesia, Drug-Induced; Excitatory Amino Acid Agents; Levodopa; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease.
Topics: Alanine; Animals; Benzylamines; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley | 2020 |
Effects of safinamide on the glutamatergic striatal network in experimental Parkinson's disease.
Topics: Alanine; Animals; Antiparkinson Agents; Benzylamines; Corpus Striatum; Dose-Response Relationship, Drug; Excitatory Postsynaptic Potentials; Glutamic Acid; Levodopa; Male; Nerve Net; Organ Culture Techniques; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar | 2020 |
Parkinson's Disease and the Heart: Studying Cardiac Metabolism in the 6-Hydroxydopamine Model.
Topics: Alanine; Animals; Neurodegenerative Diseases; Oxidopamine; Parkinson Disease; Quality of Life; Rats | 2023 |